Literature DB >> 24837103

Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation.

Yasutaka Motomura1, Hideaki Morita2, Kazuyo Moro3, Susumu Nakae4, David Artis5, Takaho A Endo6, Yoko Kuroki6, Osamu Ohara6, Shigeo Koyasu7, Masato Kubo8.   

Abstract

Allergic asthma is an inflammatory disease characterized by lung eosinophilia controlled by type 2 cytokines. Cysteine proteases are potent triggers of allergic inflammation by causing barrier disruption in lung epithelial cells inducing the elevation of interleukin-5 (IL-5) and IL-13 from natural helper (NH) cells, a member of ILC2s, which leads to lung eosinophilia. In this study, we found that basophils play a crucial role in NH cell-mediated eosinophilic inflammation induced by protease allergens. Conditional deletion of basophils caused a resolution of the papain-induced eosinophilia and mucus production. Resolution of eosinophilia was also observed in mice lacking IL-4 specifically in basophils, indicating that basophil-derived IL-4 enhanced expression of the chemokine CCL11, as well as IL-5, IL-9, and IL-13 in NH cells, thus attracting eosinophils. These results demonstrate that IL-4 from basophils has an important role in the NH-derived cytokine and chemokine expression, subsequently leading to protease allergen-induced airway inflammation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24837103     DOI: 10.1016/j.immuni.2014.04.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  114 in total

1.  Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.

Authors:  Kazuyo Moro; Hiroki Kabata; Masanobu Tanabe; Satoshi Koga; Natsuki Takeno; Miho Mochizuki; Koichi Fukunaga; Koichiro Asano; Tomoko Betsuyaku; Shigeo Koyasu
Journal:  Nat Immunol       Date:  2015-11-23       Impact factor: 25.606

2.  Basophils promote innate lymphoid cell responses in inflamed skin.

Authors:  Brian S Kim; Kelvin Wang; Mark C Siracusa; Steven A Saenz; Jonathan R Brestoff; Laurel A Monticelli; Mario Noti; Elia D Tait Wojno; Thomas C Fung; Masato Kubo; David Artis
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

Review 3.  Role of myeloid cells in the regulation of group 2 innate lymphoid cell-mediated allergic inflammation.

Authors:  Aihua Lei; Yumei He; Qiong Yang; Xiaofang Li; Ranhui Li
Journal:  Immunology       Date:  2020-08-03       Impact factor: 7.397

Review 4.  T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.

Authors:  Jinfang Zhu
Journal:  Cytokine       Date:  2015-06-01       Impact factor: 3.861

5.  The brave new world of innate lymphoid cells.

Authors:  Gérard Eberl; James P Di Santo; Eric Vivier
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

6.  Signaling pathways activated by a protease allergen in basophils.

Authors:  Rachel K Rosenstein; Jelena S Bezbradica; Shuang Yu; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

Review 7.  The biology of innate lymphoid cells.

Authors:  David Artis; Hergen Spits
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

Review 8.  Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.

Authors:  Daniel Elieh Ali Komi; Leif Bjermer
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

Review 9.  Innate lymphoid cells: major players in inflammatory diseases.

Authors:  Mikaël Ebbo; Adeline Crinier; Frédéric Vély; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2017-08-14       Impact factor: 53.106

10.  Reuse of public, genome-wide, murine eosinophil expression data for hypotheses development.

Authors:  Jillian O Grace; Astha Malik; Hadar Reichman; Ariel Munitz; Artem Barski; Patricia C Fulkerson
Journal:  J Leukoc Biol       Date:  2018-05-14       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.